These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33811195)

  • 1. Intravenous Lacosamide in Seizure Clusters: Dose and Efficacy.
    Eilam A; Khmeliov N; Penker D; Gilad R
    Clin Neuropharmacol; 2021 May-Jun 01; 44(3):85-88. PubMed ID: 33811195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
    d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
    Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
    Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
    Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy.
    Kim HK; Lee H; Bae EK; Kim DW
    Epilepsy Res; 2021 Oct; 176():106710. PubMed ID: 34265537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous lacosamide in status epilepticus and seizure clusters.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous lacosamide in clinical practice-Results from an independent registry.
    Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
    Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
    Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
    J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
    Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
    Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of lacosamide in the intensive care unit.
    Cherry S; Judd L; Muniz JC; Elzawahry H; LaRoche S
    Neurocrit Care; 2012 Apr; 16(2):294-8. PubMed ID: 22203547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study.
    Misra UK; Dubey D; Kalita J
    Epilepsy Behav; 2017 Nov; 76():110-113. PubMed ID: 28919386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
    Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
    Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.